The agency said it needed more data, including data from an ongoing study and possibly new studies, to assess Forxiga's benefits and risks.Eliquis, known chemically as apixaban, is one of a handful of new drugs meant to prevent heart attacks and strokes better than warfarin - long the standard treatment despite how tricky it is to use.